BMC Veterinary Research, published by BMC in the United Kingdom, stands as a pivotal open-access platform dedicated to advancing the field of veterinary science since its inception in 2005. With an impressive impact factor that reflects its influential presence, this journal has achieved a remarkable ranking of #17 out of 194 in the Scopus Veterinary category, placing it in the 91st percentile among its peers. The journal serves as an essential resource for researchers, professionals, and students alike, fostering the dissemination of high-quality research and innovative practices within the veterinary and broader medical communities. With its commitment to open access, BMC Veterinary Research ensures that valuable insights are accessible to all, promoting collaboration and knowledge sharing that drive the advancement of veterinary sciences. As it continues to publish significant findings until 2024, it remains a key contributor to the contemporary discourse on animal health and welfare.

New Microbes and New Infections is an esteemed peer-reviewed journal published by Elsevier Sci Ltd that has been a prominent platform for disseminating groundbreaking research in the fields of Infectious Diseases and Microbiology since its establishment in 2013. With an impressive Open Access model, this journal ensures that vital research findings are readily accessible to researchers, healthcare professionals, and academics worldwide. Positioned in the Q2 category for Infectious Diseases and Q3 for Microbiology in 2023, it reaches a significant global audience, as demonstrated by its high Scopus rankings—#44 out of 344 in Medicine: Infectious Diseases, and #34 out of 182 in Immunology and Microbiology. The journal aims to inspire new ideas and foster collaborations by publishing high-quality research focused on novel microbes and infections, thus playing a crucial role in advancing science and public health in an era where understanding infectious agents is more vital than ever.

Antibiotics-Basel is a prestigious multidisciplinary journal published by MDPI, dedicated to advancing the field of antibiotic research and management. Since its inception in 2012 as an Open Access publication, the journal has established itself as a vital resource for researchers and professionals, offering an accessible platform for the dissemination of innovative findings in Biochemistry, Infectious Diseases, Microbiology, and Pharmacology. With a solid impact in its category, Antibiotics-Basel holds a Q1 ranking in critical areas such as Pharmacology and Pharmacology, Toxicology and Pharmaceutics, making it an influential journal in its field. The journal publishes high-quality research articles, reviews, and communications that are essential for advancing our understanding of antibiotic mechanisms, resistance, and therapeutic applications. Researchers are invited to submit their manuscript to contribute to this growing body of knowledge and collaborate in the fight against antibiotic resistance and infectious diseases.

Microbial Risk Analysis, published by Elsevier, is a pivotal academic journal specializing in the intersection of epidemiology, infectious diseases, and medical microbiology. With an ISSN of 2352-3522 and an E-ISSN of 2352-3530, this journal has been contributing to the field since its inception in 2016 and continues to invite groundbreaking research as it converges through 2024. With a respectable impact factor, Microbial Risk Analysis holds a Q3 designation in key categories, showcasing its credibility with ranks such as #48 in Epidemiology and #124 in Infectious Diseases according to Scopus. The journal serves as an essential platform for researchers, professionals, and students alike, aiming to enhance understanding of microbial risks and their public health implications. Although it operates under a subscription model, its contents remain accessible to a broad range of interdisciplinary scholars dedicated to advancing microbial research. For those at the forefront of epidemiological and infectious disease studies, Microbial Risk Analysis represents a crucial resource for disseminating knowledge and fostering collaboration.

Asian Pacific Journal of Tropical Medicine, published by Wolters Kluwer Medknow Publications, stands at the forefront of research in the field of tropical medicine, contributing significantly to the global understanding of health issues prevalent in the Asian Pacific region. With an ISSN of 1995-7645 and an E-ISSN of 2352-4146, this esteemed journal has been an Open Access platform since 2011, ensuring that vital research is accessible to a broad audience. The journal boasts a commendable Scopus rank of 131 out of 636 in the General Medicine category, placing it in the 79th percentile and recognizing its influential contributions to the discipline. Based in Mumbai, India, the journal spans converged years from 2010 to 2024 and is categorized in the Q3 quartile for miscellaneous medicine as of 2023. Researchers, professionals, and students can leverage this journal to stay abreast of the latest findings and developments in tropical medicine, making it an indispensable resource in their academic and professional pursuits.

Zoonoses and Public Health is a leading peer-reviewed journal published by WILEY, based in Germany. Focused on the intersection of wildlife, domestic animal, and human health, the journal addresses critical issues concerning zoonotic diseases, their impact on public health, and strategies for prevention and control. With an impressive impact factor reflecting its significance, the journal ranks in the Q2 category across multiple fields, including Epidemiology, Public Health, and Infectious Diseases, underscoring its pivotal role in advancing research in these vital areas. As it converges from 2007 to 2024, Zoonoses and Public Health is committed to fostering interdisciplinary collaboration and publishing high-quality research that informs policy and practice. Researchers, professionals, and students alike can access vital insights through its open access options, making it an indispensable resource for anyone invested in understanding and mitigating the effects of zoonoses on public health.

Current Research in Parasitology & Vector-Borne Diseases, published by ELSEVIER, is an influential journal dedicated to advancing the understanding of parasitology and vector-borne diseases. With an ISSN of 2667-114X, this journal is highly esteemed in the field, holding a prestigious Q1 quartile ranking in categories such as Animal Science and Zoology, Insect Science, and Parasitology, as well as a notable Q2 ranking in Virology for 2023. The journal's focus spans a crucial intersection of disciplines, offering a platform for innovative research that directly addresses global health challenges posed by parasites and vectors. Researchers benefit from its robust open-access model, which facilitates unrestricted dissemination of knowledge, making essential findings accessible to a wider audience. The journal continues to play a pivotal role in fostering scholarly dialogue and interdisciplinary collaboration within the scientific community, serving as a vital resource for professionals, students, and academicians interested in the dynamic and evolving field of parasitology.

IJID Regions is a pioneering open access journal published by Elsevier, focusing on the critical fields of epidemiology, infectious diseases, and public health. Established in 2021, the journal aims to provide a platform for disseminating high-quality, innovative research that addresses pressing health issues and informs evidence-based practices in communities around the globe. With its impact factors reflecting a Tier Q2 and Q3 ranking in various medical subcategories on the Scopus platform, IJID Regions is positioned as a valuable resource for researchers, health professionals, and policy-makers striving to enhance public health outcomes. This journal not only champions open access since its inception, promoting the free flow of information, but also welcomes contributions that shed light on contemporary challenges in environmental and occupational health. Its commitment to fostering dialogue and collaboration in the health sciences is paramount, making it an essential read for those engaged in advancing public health knowledge and initiatives.

Microbiology Australia is a prominent journal published by CSIRO PUBLISHING, focusing on the diverse and rapidly evolving field of microbiology. Since its transition to Open Access in 2021, it has broadened its accessibility, fostering greater dissemination of research findings among scholars and practitioners. The journal features a range of topics that are pivotal for understanding microbial systems in applied microbiology, medical microbiology, public health, and environmental applications. Despite its current categorization in the Q4 quartile across several categories, it remains an essential platform for emerging research and innovative methodologies. Researchers and professionals can benefit from the journal's commitment to enriching the global discourse on microbiological advancements. With its ISSN 1324-4272 and E-ISSN 2201-9189, Microbiology Australia caters to a wide audience in Australia and beyond, making significant strides in bridging the gap between research and practical applications in microbiology.

Eurosurveillance is a prestigious journal dedicated to the field of epidemiology, public health, and infectious diseases, published by the European Centre for Disease Prevention and Control since 1996. With an impressive Q1 ranking across various categories, including Epidemiology and Public Health, it consistently stands at the forefront of research dissemination, making it an invaluable resource for researchers, professionals, and students alike. The journal boasts an outstanding reputation, as evidenced by its Scopus rankings, where it ranks in the top 1% to 3% in multiple relevant categories. As an Open Access publication, Eurosurveillance ensures that vital findings are freely accessible to a global audience, fostering collaboration and innovation in the fight against infectious diseases. With a dedicated reach from 2001 to 2024, the journal addresses contemporary challenges in public health and virology, reinforcing its significance in shaping policies and research initiatives across the world.